2024 年全球临床诊断展望

数位服务和自动化有助于分子诊断和 POCT 产业在 COVID-19 大流行后恢復

随着 COVID-19 大流行的结束，临床诊断行业继续从集中式测试模式过渡到分散式检查模式，医疗保健提供者将其大部分能力用于预防性医疗保健和精准医疗。从全球来看，2024年预计将是临床检测产业获利的一年，持续成长预计将持续到2029年。主要驱动力将是 POCT 和分子诊断领域，Frost & Sullivan 预测这些领域将在 2024 年出现更强劲的復苏。

本研究检视了世界五个地区 2024 年至 2029 年的临床诊断产业趋势和成长预测。我们分析创新的体外诊断技术和应用、值得关注的主要供应商以及疫情后现实中的成长机会。它还提出了 2024 年关于产业去中心化趋势、分子诊断復苏以及自动化解决方案和新数位模型投资增加的五项预测。

目录

分析亮点

• 分析亮点
• 2023 年临床诊断产业：预测与实际
• 2024年主要临床诊断预测

策略要务

• 为什么成长如此困难？
• The Strategic Imperative 8（TM）
• 关键策略要务对临床诊断产业的影响
• 成长机会推动Growth Pipeline Engine（TM）

成长环境

宏观经济因素

收益趋势 - 2024 年

• 预测假设：临床诊断产业
• 临床诊断产业（按细分市场）
• 收益预测（按子区隔）
• 收益预测（按细分市场）：强化检查
• 收益预测，按细分市场：推荐/週边设备、分散式检查
• 按地区分類的收益预测
• 按地区分類的收入比例预测
• 按地区分類的收益预测分析
• 竞争环境
• 收益占有率
• 收益占有率分析
• 竞赛矩阵

併购

• 着名併购
• 併购：过去的分析

预测前 5 名 - 2024 年

• 预测1：长期消费行为变化将支持扩大自收集测试范围
• 预测2：人手不足将持续推动实验室自动化实现两位数成长
• 预测 3：采用 NGS 和专业生物资讯学工具将帮助製药公司创新
• 预测4：ctDNA分析将扩大MRD检测在精准肿瘤学的应用
• 预测 5：与专注于人工智慧的Start-Ups的合作将推动基于人工智慧的数位病理学在临床领域的采用

行业概况 - 2024 年

临床化学/免疫测量-2024

• 临床化学和免疫测量产业概况
• 临床化学/免疫测量产业：知名企业

分子诊断 - 2024

现场检验 - 2024

组织诊断 - 2024

成长机会宇宙

• 成长机会1：转向数位诊断服务
• 成长机会 2：扩展到临床化学和免疫测量的新兴市场
• 成长机会3：遗传学和心血管疾病分子诊断的预测测试
• 成长机会 4：临床环境中的分子 POCT
• 成长机会 5：用于免疫测量、STI 和 AMR 应用的多重 POCT

结论

下一步

Driven by Digital Services and Automation, the Molecular Diagnostics and POCT Sectors Rebound after the COVID-19 Pandemic

With the end of the COVID-19 pandemic, healthcare providers have been directing most of their capabilities toward preventive healthcare and precision medicine, as the clinical diagnostics industry continues its transition from a centralized to a decentralized testing model. Globally, 2024 is set to be a profitable year for the industry, which will likely witness sustained growth through to 2029. The main growth drivers will be the point-of-care testing (POCT) and molecular diagnostics sectors, which Frost & Sullivan expects to rebound even more strongly in 2024.

This study examines clinical diagnostics industry trends and growth projections from 2024 to 2029 across five global regions. It analyzes innovative in vitro diagnostics technologies and applications, major vendors to watch, and growth opportunities in the post-pandemic reality. The research also provides the top 5 predictions for 2024 related to the industry's decentralization trend, the recovery of molecular diagnostics, and the higher investments in automated solutions and novel digital models.

Table of Contents

Analysis Highlights

• Analysis Highlights
• The 2023 Clinical Diagnostics Industry: Forecast vs. Actual
• Top Clinical Diagnostics Predictions for 2024

Strategic Imperatives

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Clinical Diagnostics Industry
• Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Environment

• Segmentation
• Growth Environment

Macroeconomic Factors

• Top 10 Trends for 2024
• Top 10 Growth Opportunities
• 1. Global GDP Growth-Mild Global Growth Slowdown from 3.0% in 2023 to 2.6% in 2024 as Key Economies Lose Growth Momentum
• 2. Inflation and Interest Rates-Headline Inflation to Continue to Decline; H2 2024 Shift Toward Rate Cuts for Advanced Economies
• 3. Currency Trajectory-Dollar to Remain Strong in H1 2024; Emerging Market Currencies to Get Boost from Q3 2024 Onwards
• 4. Labor Market-Moderate Unemployment Uptick; Positive Expectations Over Market Sentiment to Support Labor Hoarding
• 5. Oil Markets-Q1 OPEC+ Oil Production Cuts; Non-OPEC Production to Rise
• 6. Critical Minerals Supplies-Need for Economic Resiliency to Bolster Cross-border and Cross-industry Partnerships
• 7. North America-Economic Slowdown Amidst Discretionary Spending Pullback and Elevated Interest Rates
• 8. Western Europe-Moderate Growth Pick-up as Inflation Headwinds Ease Gradually; Rebuilding Fiscal Buffers to Take Precedence
• 9. Middle East-Non-oil Growth Driven by Economic Diversification to Limit Pullback Caused by a Slowdown in Global Oil Markets
• 10. Asia-Emerging Economies to Drive Growth Momentum; Fiscal Measures to Support Chinese Economic Recovery

Revenue Trends-2024

• Forecast Assumptions: Clinical Diagnostics Industry
• Clinical Diagnostics Industry by Segment
• Revenue Forecast by Subsegment
• Revenue Forecast by Segment: Centralized Testing
• Revenue Forecast by Segment: Referral & Peripheral and Decentralized Testing
• Revenue Forecast by Region
• Percent Revenue Forecast by Region
• Revenue Forecast Analysis by Region
• Competitive Environment
• Revenue Share
• Revenue Share Analysis
• Competitor Matrix

Mergers and Acquisitions

• Notable M&As in 2023
• M&As: Historical Analytics

Top 5 Predictions-2024

• Prediction 1: Long-term Change in Consumer Behavior Supports Expansion into Self-collection Testing
• Prediction 2: Staff Shortages Continue to Drive Double-digit Lab Automation Growth Rate
• Prediction 3: Adoption of NGS and Specialized Bioinformatics Tools Will Support Pharma Innovation
• Prediction 4: ctDNA Analysis Will Expand the Application of MRD Testing for Precision Oncology
• Prediction 5: Partnerships with AI-focused Start-ups to Promote Adoption of AI-based Digital Pathology in Clinical Segments

Industry Snapshot-2024

• 2024 Industry Snapshot

Clinical Chemistry and Immunoassays-2024

• Clinical Chemistry and Immunoassays Industry Snapshot
• Clinical Chemistry and Immunoassays Industry: Companies to Watch

Molecular Diagnostics-2024

• Molecular Diagnostics Industry Snapshot
• Molecular Diagnostics Industry: Companies to Watch

POCT-2024

• POCT Industry Snapshot
• POCT Industry: Companies to Watch

Tissue Diagnostics-2024

• Tissue Diagnostics Industry Snapshot
• Tissue Diagnostics Industry: Companies to Watch

Growth Opportunity Universe

• Growth Opportunity 1: Shift toward Digital Diagnostics Services
• Growth Opportunity 2: Expansion of Clinical Chemistry and Immunoassays to Emerging Markets
• Growth Opportunity 3: Predictive Testing in Molecular Diagnostics for Genetics and Cardiovascular Diseases
• Growth Opportunity 4: Molecular POCT in Clinical Settings
• Growth Opportunity 5: Multiplex POCT for Immunoassay, STI, and AMR Applications

Conclusions

• Conclusions and Future Outlook

Next Steps

• Your Next Steps
• Why Frost, Why Now?
• List of Exhibits
• Legal Disclaimer